The recombinant Corynebacterium jeikeium UPF0233 membrane protein Jk0035 (Jk0035) is a full-length, His-tagged protein expressed in E. coli for research purposes. It is annotated as a cell division protein (CrgA) with the UniProt identifier Q4JYC3. This protein is critical for understanding bacterial cell division mechanisms and pathogenicity, particularly in C. jeikeium, a multidrug-resistant opportunistic pathogen implicated in severe infections in immunocompromised patients .
Whole-genome sequencing of C. jeikeium isolates revealed significant divergence, with four distinct genomospecies identified . While crgA is conserved in the reference strain K411, its presence or variability across other C. jeikeium subgroups remains uncharacterized .
C. jeikeium is a lipophilic, multidrug-resistant pathogen causing bacteremia, endocarditis, and device-associated infections, particularly in immunocompromised patients . While Jk0035’s direct role in pathogenicity is not explicitly described, its association with cell division suggests potential involvement in bacterial proliferation during infection.
C. jeikeium exhibits resistance to β-lactams, macrolides, and fluoroquinolones but remains susceptible to vancomycin and rifampicin .
Dormant C. jeikeium cells, resistant to vancomycin and heat, may evade antibiotic treatment, complicating infection management .
The recombinant Jk0035 protein is primarily used for:
Structural Studies: Elucidating membrane protein topology and interactions.
Antigenic Profiling: Investigating immune evasion mechanisms in C. jeikeium.
Drug Target Validation: Screening inhibitors of bacterial cell division.
Functional Studies: No peer-reviewed studies directly linking Jk0035/CrgA to bacterial cell division or virulence mechanisms.
Genomic Context: Limited data on crgA expression, regulation, or interaction partners in C. jeikeium.
KEGG: cjk:jk0035
STRING: 306537.jk0035
Corynebacterium jeikeium UPF0233 membrane protein jk0035 (UniProt ID: Q4JYC3) is a 90-amino acid membrane protein also known as CrgA (Cell division protein CrgA). The full amino acid sequence is: MPKSKVNSAEENYSSSSSADRRTPVKLNSSGTPRWYIVLMLALMLLGLAWLVVNYIAGPE IPFMRDLNAWNYLIGFALLIVGLLMTMGWK . This protein belongs to the UPF0233 family of membrane proteins and is found in Corynebacterium jeikeium, a bacterium associated with serious infections, particularly in immunocompromised patients. C. jeikeium is notably linked to bacteremia in patients with hematologic malignancies, with a 30% mortality rate in true bacteremia cases .
The optimal reconstitution method for recombinant jk0035 protein involves:
Brief centrifugation of the vial prior to opening to bring contents to the bottom
Reconstitution in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Addition of glycerol (5-50% final concentration) as a cryoprotectant
Aliquoting for long-term storage to avoid freeze-thaw cycles
For experimental work, researchers should consider reconstituting the protein in a buffer system that maintains physiological pH (typically Tris/PBS-based buffer, pH 8.0), as the protein is typically lyophilized in this buffer with 6% trehalose as a stabilizing agent .
The jk0035 protein has several notable structural characteristics:
A full length of 90 amino acids
Hydrophobic regions consistent with transmembrane domains (evident from the amino acid sequence with stretches of hydrophobic amino acids: WYIVLMLALMLLGLAWLVVNY and NYWNYLIGFALLIVGLLMTMGWK)
Likely orientation across the bacterial cell membrane based on its sequence characteristics
The membrane integration of this protein makes structural studies challenging, similar to other membrane proteins that require specialized techniques such as cryo-EM or X-ray crystallography following stabilization in lipid nanoparticles or detergent micelles .
Based on current advances in membrane protein research, the following methodologies are most effective for structural analysis of jk0035:
Methodology | Advantages | Limitations | Sample Requirements |
---|---|---|---|
Cryo-electron microscopy (cryo-EM) | High resolution (potentially atomic), preserves native-like environment | Requires specialized equipment, computational expertise | ~0.1-0.5 mg of pure protein in stable form |
Lipid nanoparticle reconstitution | Preserves native lipid environment, stabilizes protein | Complex optimization required | 1-5 mg of purified protein |
Surface plasmon resonance (SPR) | Enables real-time binding analysis | Indirect structural information | Stable, active protein immobilized on chip |
Nuclear magnetic resonance (NMR) | Dynamic information, solution-state structure | Size limitations | Isotopically labeled protein (15N, 13C) |
For jk0035 specifically, direct extraction into lipid Salipro nanoparticles from expression systems might be particularly effective, allowing for subsequent structure-function analysis using SPR and cryo-EM . This approach has been successful with other challenging membrane proteins and could be adapted for jk0035.
The function of jk0035, also known as cell division protein CrgA, may have significant implications for C. jeikeium pathogenesis based on clinical observations:
C. jeikeium causes true bacteremia at significantly higher rates (71%) than other Corynebacterium species (except C. striatum)
C. jeikeium bacteremia is particularly common in patients with hematologic malignancies (64% of cases) and neutropenia
The 90-day mortality rate for C. jeikeium bacteremia is approximately 30%
Given that jk0035/CrgA is involved in cell division, it may contribute to pathogenesis through:
Regulation of bacterial replication during infection
Adaptation to the host environment during bacteremia
Potential interactions with host immune cells or proteins
Possible role in antimicrobial resistance mechanisms
Experimental approaches to investigate this relationship would include:
Construction of jk0035 knockout mutants and assessment of virulence in vitro and in vivo
Transcriptomic analysis comparing jk0035 expression levels in clinical isolates versus laboratory strains
Protein-protein interaction studies to identify host targets of jk0035 during infection
Expressing and purifying functional jk0035 presents several significant challenges:
Membrane protein solubility issues:
Hydrophobic transmembrane domains can cause aggregation
Selection of appropriate detergents is critical for extraction from membranes
Maintaining native-like conformation during purification requires careful optimization
Expression system considerations:
Purification strategy optimization:
Metal affinity chromatography using His-tag is effective but requires optimization of imidazole concentrations
Size exclusion chromatography helps separate monomeric from aggregated protein
Quality control through SDS-PAGE and Western blotting is essential to confirm purity (>90% is typically achievable)
Functional assessment challenges:
Lack of established activity assays for jk0035
Need for reconstitution into membrane-like environments to assess function
Limited knowledge of binding partners or substrates
Researchers have overcome similar challenges with other membrane proteins by using novel extraction methods that directly incorporate the protein into lipid nanoparticles, preserving functionality for downstream analyses .
A comprehensive experimental design to elucidate the role of jk0035 in clinical isolates would include:
Clinical isolate characterization:
Collection of C. jeikeium isolates from bacteremia cases, particularly from patients with hematologic malignancies
Genome sequencing to identify polymorphisms in the jk0035 gene
Transcriptomic analysis to determine jk0035 expression levels in different clinical contexts
Genetic manipulation experiments:
Construction of jk0035 knockout mutants using CRISPR-Cas9 or traditional homologous recombination
Complementation studies to confirm phenotypes
Site-directed mutagenesis to assess the impact of clinically observed polymorphisms
Phenotypic characterization:
Growth curves under various conditions (temperature, pH, nutrient limitation)
Cell morphology and division pattern analysis using electron microscopy
Antibiotic susceptibility testing compared to wild-type strains
Biofilm formation capacity assessment
Host-pathogen interaction studies:
Adhesion and invasion assays using relevant human cell lines
Neutrophil survival assays (particularly relevant given association with neutropenic patients)
Serum resistance testing
In vivo infection models (if ethically approved)
Proteomic approaches:
Identification of jk0035 interaction partners using pull-down assays
Phosphoproteomics to identify signaling pathways affected by jk0035
Comparative proteomics between wild-type and jk0035 mutants
This multifaceted approach would provide comprehensive insights into the role of jk0035 in clinically relevant contexts, particularly its potential contribution to the high mortality associated with C. jeikeium bacteremia in patients with hematologic malignancies .
Understanding membrane protein dynamics requires specialized methodological approaches:
Hydrogen-deuterium exchange mass spectrometry (HDX-MS):
Provides information on protein flexibility and conformational changes
Can identify regions involved in ligand binding or protein-protein interactions
Requires careful optimization for membrane proteins like jk0035
Single-molecule Förster resonance energy transfer (smFRET):
Measures distances between fluorescently labeled residues
Captures conformational dynamics in real-time
Requires strategic placement of fluorophores based on structural predictions
Molecular dynamics (MD) simulations:
Predicts protein behavior in membrane environments
Can model conformational changes over nanosecond to microsecond timescales
Requires validation with experimental data
Site-directed spin labeling with electron paramagnetic resonance (SDSL-EPR):
Measures distances between spin-labeled residues
Works well in membrane environments
Provides information on conformational distributions
Similar approaches have been successfully applied to study other bacterial membrane proteins, such as AVPR2, where disease-causing mutations were found to alter structural dynamics . For jk0035, these techniques could reveal how the protein functions in cell division and potentially identify targets for therapeutic intervention against C. jeikeium infections.
When designing experiments to study jk0035 function, the following controls are essential:
Negative controls:
Heat-denatured jk0035 protein to confirm activity is protein-specific
Empty vector-expressed product purified identically to control for host cell contaminants
Buffer-only controls for all functional assays
Positive controls:
Well-characterized membrane protein with similar size/structure
Native (non-recombinant) jk0035 if available
Recombinant protein with known activity from the same expression system
Specificity controls:
Structurally similar but functionally distinct membrane proteins
Antibody pre-absorption controls for immunological detection
Competitive binding assays with unlabeled protein
Expression system controls:
Comparison of E. coli-expressed protein with protein expressed in other systems
Tag-free protein compared to His-tagged version to assess tag interference
Multiple purification lots to ensure reproducibility
Proper controls ensure that observed effects are specifically attributable to jk0035 function rather than experimental artifacts or contaminants.
Accurate assessment of jk0035 purity and functionality requires multiple complementary techniques:
For membrane proteins like jk0035, additional considerations include:
Detergent screening to identify optimal conditions for stability
Reconstitution into proteoliposomes to verify membrane integration
Assessment of orientation in membranes through protease protection assays
These multifaceted approaches ensure that subsequent functional studies are performed with properly folded, pure, and active protein preparations.
Understanding jk0035 structure and function could contribute to novel therapeutic approaches in several ways:
Drug target potential:
As a membrane protein involved in cell division, jk0035 represents a potential antibiotic target
Structural information could enable structure-based drug design
Inhibiting jk0035 function might specifically target C. jeikeium without affecting beneficial microbiota
Relevance to high-risk populations:
Addressing antibiotic resistance:
C. jeikeium isolates show resistance to multiple antibiotics
Novel targets like jk0035 could overcome existing resistance mechanisms
Combination therapies targeting jk0035 and other pathways might prevent resistance development
Diagnostic applications:
Recombinant jk0035 could be used to develop specific antibodies for rapid C. jeikeium detection
Expression patterns of jk0035 might serve as biomarkers for virulence or treatment response
Understanding jk0035 function might explain the high rate (71%) of true bacteremia caused by C. jeikeium compared to other Corynebacterium species
Research into membrane proteins has already shown promise for developing new therapeutics for other diseases, as demonstrated by work on AVPR2 for diabetes insipidus , suggesting similar potential for jk0035-targeted approaches.
Several bioinformatic approaches can be applied to predict potential interaction partners of jk0035:
Homology-based prediction:
Identification of interaction partners of homologous proteins in related species
Application of interolog mapping (transfer of protein interactions across species)
Phylogenetic profiling to identify proteins with similar evolutionary patterns
Structure-based prediction:
Molecular docking simulations with potential partners
Interface prediction using surface characteristics
Coarse-grained molecular dynamics to assess binding energetics
Genomic context methods:
Operon analysis to identify functionally related genes
Gene neighborhood conservation across species
Gene fusion events indicating functional relationships
Network-based approaches:
Co-expression network analysis using transcriptomic data
Protein-protein interaction network integration
Text mining of scientific literature for reported associations
Machine learning approaches:
Integration of multiple data types for partner prediction
Feature-based classification of potential interactions
Deep learning methods for interaction prediction from sequence data
These computational predictions would require experimental validation through techniques such as co-immunoprecipitation, bacterial two-hybrid systems, or direct binding assays using the recombinant protein.
Expressing membrane proteins like jk0035 in heterologous systems presents significant challenges that can be addressed through several strategies:
Expression system optimization:
E. coli strains specifically designed for membrane protein expression (C41, C43, Lemo21)
Use of weak promoters to prevent overwhelming the membrane insertion machinery
Low-temperature induction to slow protein production and improve folding
Codon optimization for the expression host
Fusion partner approaches:
N-terminal fusions with highly soluble proteins (MBP, SUMO, Trx)
Addition of signal sequences for proper membrane targeting
Strategic placement of affinity tags to avoid interference with membrane domains
Media and growth condition optimization:
Supplementation with specific lipids similar to native C. jeikeium membrane
Addition of chemical chaperones to improve folding
Osmotic stress adaptation to enhance membrane protein yield
Use of defined minimal media to control growth rate
Alternative expression systems:
Cell-free expression systems with supplied lipids or detergents
Yeast expression systems for eukaryotic-like quality control
Insect cell expression for complex membrane proteins
Direct extraction methods:
These approaches have been successfully applied to other challenging membrane proteins and could be adapted for jk0035 expression and purification, potentially improving yield and maintaining native conformation and function.
Assessing membrane integration and orientation of recombinant jk0035 requires specialized techniques:
Protease protection assays:
Treatment of proteoliposomes with proteases that cannot cross membranes
Analysis of protected fragments by mass spectrometry
Comparison with computational topology predictions
Fluorescence-based approaches:
Site-specific labeling of predicted extramembranous regions
Quenching experiments with membrane-impermeable quenchers
FRET measurements between strategically placed fluorophores
Antibody accessibility studies:
Generation of antibodies against specific domains
Differential accessibility in intact versus permeabilized membranes
Immunogold electron microscopy for direct visualization
Chemical modification approaches:
Selective labeling of accessible cysteine residues
Mass spectrometry to identify modified sites
Comparison with computational topology models
Biophysical techniques:
Attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR)
Oriented circular dichroism (OCD)
Neutron reflectometry for membrane positioning
These methodologies provide complementary information about membrane integration and orientation, crucial for understanding jk0035 function and for the development of targeted therapeutics against C. jeikeium infections.